These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Molecular modeling of the complex between Torpedo acetylcholine receptor and anti-MIR Fab198. Konstantakaki M; Tzartos SJ; Poulas K; Eliopoulos E Biochem Biophys Res Commun; 2007 May; 356(3):569-75. PubMed ID: 17376405 [TBL] [Abstract][Full Text] [Related]
6. Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries. Rey E; Zeidel M; Rhine C; Tami J; Krolick K; Fischbach M; Sanz I Clin Immunol; 2000 Sep; 96(3):269-79. PubMed ID: 10964546 [TBL] [Abstract][Full Text] [Related]
7. Myasthenia gravis studied by monoclonal antibodies to the acetylcholine receptor. Tzartos SJ In Vivo; 1988; 2(1):105-10. PubMed ID: 2979808 [TBL] [Abstract][Full Text] [Related]
8. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope. Atassi MZ; Oshima M; Deitiker P Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597 [TBL] [Abstract][Full Text] [Related]
9. Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor. Loutrari H; Kokla A; Tzartos SJ Eur J Immunol; 1992 Sep; 22(9):2449-52. PubMed ID: 1516631 [TBL] [Abstract][Full Text] [Related]
10. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis. Kawanami S; Tsuji R; Oda K Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620 [TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of human anti-acetylcholine receptor monoclonal antibodies from transgenic mice expressing human immunoglobulin loci. Protopapadakis E; Kokla A; Tzartos SJ; Mamalaki A Eur J Immunol; 2005 Jun; 35(6):1960-8. PubMed ID: 15915538 [TBL] [Abstract][Full Text] [Related]
13. Effector mechanisms in myasthenia gravis: end-plate function after passive transfer of IgG, Fab, and F(ab')2 hybrid molecules. Sterz R; Hohlfeld R; Rajki K; Kaul M; Heininger K; Peper K; Toyka KV Muscle Nerve; 1986 May; 9(4):306-12. PubMed ID: 2423869 [TBL] [Abstract][Full Text] [Related]
14. Clonotypic analysis of anti-acetylcholine receptor antibodies from experimental autoimmune myasthenia gravis-sensitive Lewis rats and experimental autoimmune myasthenia gravis-resistant Wistar Furth rats. Zoda T; Yeh TM; Krolick KA J Immunol; 1991 Jan; 146(2):663-70. PubMed ID: 1987281 [TBL] [Abstract][Full Text] [Related]
15. Suppression of development of experimental autoimmune myasthenia gravis with isogeneic monoclonal anti-idiotopic antibody. Agius MA; Richman DP J Immunol; 1986 Oct; 137(7):2195-8. PubMed ID: 3489757 [TBL] [Abstract][Full Text] [Related]
16. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera. Tzartos SJ; Sophianos D; Efthimiadis A J Immunol; 1985 Apr; 134(4):2343-9. PubMed ID: 3973387 [TBL] [Abstract][Full Text] [Related]
17. A rapid, fluorescence-based assay for detecting antigenic modulation of the acetylcholine receptor on human cell lines. Keefe D; Hess D; Bosco J; Tzartos S; Powell J; Lamsa J; Josiah S Cytometry B Clin Cytom; 2009 May; 76(3):206-12. PubMed ID: 18825779 [TBL] [Abstract][Full Text] [Related]
18. Myasthenic sera recognize the human acetylcholine receptor bound to thymopoietin. Morel E; Vernet-der Garabedian B; Raimond F; Audhya TK; Goldstein G; Bach JF Eur J Immunol; 1987 Aug; 17(8):1109-13. PubMed ID: 3622601 [TBL] [Abstract][Full Text] [Related]
19. High affinity single-chain Fv antibody fragments protecting the human nicotinic acetylcholine receptor. Tsantili P; Tzartos SJ; Mamalaki A J Neuroimmunol; 1999 Feb; 94(1-2):15-27. PubMed ID: 10376932 [TBL] [Abstract][Full Text] [Related]